Breaking News

Tweet TWEET

Illumina Names Francis deSouza as President

  Illumina Names Francis deSouza as President

Business Wire

SAN DIEGO -- November 11, 2013

Illumina, Inc. (NASDAQ:ILMN) today announced it has appointed Francis deSouza
to the role of President. Mr. deSouza will report to Chief Executive Officer
Jay Flatley and will lead Illumina's business units and the core functions
responsible for envisioning, developing and producing the company’s products.
He will also become part of Illumina's executive management team, which is
responsible for directing all aspects of company strategy, planning and
operations. Mr. deSouza has nearly two decades of technology experience and
has successfully brought products to market in startups and large
organizations.

“Francis' broad technology background, his experience in providing complex
technology solutions, and his roles in scaling and leading both
entrepreneurial startups and large enterprises make him ideal for the role,”
said Jay Flatley. “We are very excited to have Francis join our team as he
brings a unique combination of global expertise, business acumen and
technology depth.”

Mr. deSouza currently serves as President of Products & Services at Symantec
Corporation, where he is responsible for driving the vision for Symantec’s
market-leading portfolio, and is part of the executive team setting the
company’s strategic direction. Prior to his current role, he served in a
variety of executive roles at Symantec, joining the company through the
acquisition of IMlogic in February of 2006, where he was co-founder and CEO.
Before his years at IMlogic and Symantec, Mr. deSouza was co-founder and CEO
of Flash Communications, a provider of corporate instant messaging that was
acquired by Microsoft in 1998. Following that acquisition, he joined Microsoft
and led the team responsible for the development of the company's enterprise
real-time collaboration offerings. He currently serves as Chairman of the
Board for MedHelp, the world’s largest online health community. Mr. deSouza
holds a number of patents in computer security, and graduated from the
Massachusetts Institute of Technology with MS and BS degrees in Electrical
Engineering and Computer Science. Mr. deSouza will join the Illumina team in
December.

About Illumina

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer
of life science tools and integrated systems for the analysis of genetic
variation and function. We provide innovative sequencing and array-based
solutions for genotyping, copy number variation analysis, methylation studies,
gene expression profiling, and low-multiplex analysis of DNA, RNA, and
protein. We also provide tools and services that are fueling advances in
consumer genomics and diagnostics. Our technology and products accelerate
genetic analysis research and its application, paving the way for molecular
medicine and ultimately transforming healthcare.

Contact:

Illumina, Inc.
Investors:
Rebecca Chambers
858-255-5243
rchambers@illumina.com
or
Media:
Jennifer Temple
858-882-6822
pr@illumina.com
 
Press spacebar to pause and continue. Press esc to stop.